# NCT04303780 (NCT04303780)

> Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04303780
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Amgen
- Conditions: KRAS p, G12c Mutated /Advanced Metastatic NSCLC
- Interventions: AMG 510; Docetaxel
- Enrollment: 345
- Primary outcome: Progression-free Survival (PFS)

## Commentary we found

- X threads: 73
- Podcasts: 34
- YouTube: 20

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct04303780

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04303780", "email": "<work email>"}; the inbox owner confirms by the emailed link.